{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-24-000018","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.326700+00:00","generated_at":"2026-06-06T07:35:28.540670+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"McKesson FQ3 revenue $80.9B (+15% YoY), adjusted EPS $7.74 (+12%), raises FY guidance","bullets":["Revenue $80.9B up 15% YoY; GAAP EPS from continuing ops $4.42 vs $7.65 (down 42%).","Adjusted EPS $7.74 vs $6.90; adjusted earnings $1,032M up 6%.","FY 2024 adjusted EPS guidance raised to $27.25-$27.65 from $26.80-$27.40.","US Oncology Network added Nashville Oncology Associates and SCRI Oncology Partners.","Year-to-date revenue $232.6B (+12%); adjusted EPS $21.24 (+13%)."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-24-000018","json":"https://secwatch.observer/filing/0000927653-24-000018.json","markdown":"https://secwatch.observer/filing/0000927653-24-000018.md","text":"https://secwatch.observer/filing/0000927653-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/0000927653-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/mck-20240207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:35:28.540670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6d5d92fe7d56e99b1d959c9a69b11d7fd1fc5e97","claim":"MCKESSON CORP reported the third quarter ended December 31, 2023 results: revenue $80,898, net income $589, EPS $4.42. Guidance raised.","evidence_excerpt":"December 31, 2023. Fiscal 2024 Third Quarter Result Summary Third Quarter Year-to-Date ($ in millions, except per share amounts) FY24 FY23 Change FY24 FY23 Change Revenues $ 80,898 $ 70,490 15 % $ 232,596 $ 207,801 12 % Income from Continuing Operations 2 589 1,078 (45) 2,211 2,776 (20) Adjusted Earnings 2,3 1,032 972 6 2,866 2,697 6 Earnings per Diluted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/0000927653-24-000018-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended December 31, 2023"},{"label":"Revenue","value":"$80,898"},{"label":"Net income","value":"$589"},{"label":"EPS","value":"$4.42"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}